• Citer

Treatment with terlipressin as a bridge to liver transplantation in a patient with hepatorenal syndrome

par Le Moine, Olivier ;El Nawar, A.;Jagodzinski, Robert;Bourgeois, Nadine ;Adler, Michael ;Gelin, Michel ;Cremer, Michel
Référence Acta gastro-enterologica Belgica (Ed. multilingue), 61, 2, page (268-270)
Publication Publié, 1998

Article révisé par les pairs

• Détails
• Contenu

Résumé :

Hepatorenal syndrome is a rapidly lethal complication of cirrhosis. The present case provides further evidence of the efficacy of terlipressin in this context even with concomitant treatment with propranolol. A 56 year old male with HBV related cirrhosis developed renal failure characteristic of hepatorenal syndrome. He was also taking propranolol for primary prophylaxis of variceal bleeding. Terlipressin 6 mg/day was administered during haemodialysis and after 1 week plasma creatinine dropped from 6.2 to 2.8 mg%. Daily urinary volume, plasma sodium and natriuresis dramatically increased during the treatment. Discontinuation of the treatment led to a rapid relapse of renal failure (plasma creatinine from 1.8 to 2.2 mg%) and the drug was readministered until a successful liver transplantation could be performed 1 month after the beginning of the treatment. The patient has now a near normal renal function 3 months after transplantation.